Murphy, Grainne
Isenberg, David A.
Article History
First Online: 5 June 2019
Change Date: 3 July 2019
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: D.A.I. declares that he has received honoraria from AstraZeneca, Celgene, Eli Lilly, Merck Serono, Roche, UCB and XTL Biopharmaceuticals. G.M. declares no competing interests.